Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Incobotulinumtoxin A by Merz Pharma GmbH & Co for Neuromuscular Disorders: Likelihood of Approval
Incobotulinumtoxin A is under clinical development by Merz Pharma GmbH & Co and currently in Phase II for Neuromuscular Disorders....
Data Insights
Incobotulinumtoxin A by Merz Pharma GmbH & Co for Peripheral Neuropathic Pain: Likelihood of Approval
Incobotulinumtoxin A is under clinical development by Merz Pharma GmbH & Co and currently in Phase II for Peripheral Neuropathic...